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ABSTRACT
Objectives: Hysterectomies may be performed unneces-
sarily in women with chronic pelvic pain if the diagnosis
of interstitial cystitis is not considered. The objectives of
this study were to investigate the prevalence of interstitial
cystitis in patients with posthysterectomy chronic pelvic
pain and to evaluate the efficacy of various therapies for
interstitial cystitis.
Methods: A study was performed of 111 patients with
chronic pelvic pain whose pain persisted after hysterec-
tomy. Patients were screened with the Pelvic Pain and
Urgency/Frequency symptom scale, and underwent Po-
tassium Sensitivity Testing. Patients were treated with di-
etary changes alone or in combination with cystoscopic
hydrodistention or oral pentosan polysulfate, or both of
these, for 3 to 6 months.
Results: Of the 111 patients enrolled, 79% (n88) were
diagnosed with bladder dysfunction consistent with inter-
stitial cystitis. For patients treated with dietary modifica-
tion alone (n33), the mean score on the Pelvic Pain and
Urgency/Frequency questionnaire improved 15.4%, from
13.18 at baseline to 11.15 at follow-up. For patients treated
with pentosan polysulfate or cystoscopic hydrodistention,
or both, plus diet changes (n78), Pelvic Pain and Urgen-
cy/Frequency scores improved 34.2%, from 15.01 to 9.87.
Conclusion: In this study, nonsurgical treatment for in-
terstitial cystitis resulted in a marked improvement in
symptoms that had not improved with surgery. Without
determining the origin of bladder pain, gynecologists
should not proceed to hysterectomy in patients with
chronic pelvic pain.
Key Words: Chronic pelvic pain, Posthysterectomy pain,
Bladder-origin pain, Interstitial cystitis, Potassium Sensitivity
Test, Pelvic Pain and Urgency/Frequency questionnaire.
INTRODUCTION
Chronic pelvic pain (CPP), defined as nonmenstrual pel-
vic pain that occurs for more than 6 months, is a debili-
tating condition that affects approximately 9 million
women in the United States.1,2 Chronic pelvic pain can
have multiple causes, including disorders of the reproduc-
tive tract, gastrointestinal system, urologic organs, the
musculoskeletal system, and the psychoneurological sys-
tem.2 Therefore, this condition is often difficult to diag-
nose accurately and is frustrating to treat.3 Of the approx-
imately 600,000 hysterectomies performed annually in the
United States, 10% to 20% result from a diagnosis of
CPP.2,4–7
Although hysterectomy is often effective for the relief of
symptoms associated with CPP, several studies indicate
that up to 38% of women report persistent postoperative
CPP.3,6,8,9 In those patients with persistent posthysterec-
tomy CPP, often no evidence is present of uterine pathol-
ogy on postoperative examination.2 This evidence sug-
gests that hysterectomies may be performed unnecessarily
in some patients with CPP.
The Maryland Women’s Health Study, a large 2-year pro-
spective study of 1299 women, was designed to assess the
efficacy of hysterectomies in benign conditions, including
pelvic pain.8 Over the 2-year posthysterectomy follow-up
period, patients experienced a substantial improvement in
symptoms, including pelvic pain (Table 1).8 Although
many patients had postoperative improvements, 8.5% of
patients had persistent pelvic pain at 1 year posthysterec-
tomy.8 Another large prospective study, the Maine Wom-
en’s Health Study, examined the rate of relief for specific
symptoms in 418 women who had a hysterectomy for any
nonmalignant condition.6 One year after surgery, persis-
tent pelvic pain was reported in 5% of patients who had
some degree of pelvic pain before hysterectomy.6 In both
the Maine and Maryland studies, problems with urination
(frequency, urgency, or incontinence) persisted in ap-
proximately 9% of patients.6,8
Two additional studies evaluated patient outcomes after
hysterectomy. In a study by Hillis et al9 of 308 women
who underwent hysterectomy for CPP, 279 of whom were
available for follow-up at 1 year, 21% (58/279) reported
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SCIENTIFIC PAPERcontinued but decreased pain. Of the total study cohort of
308, 5%15 reported that their pain was unchanged (2.5%,
7) or increased (2.5%, 8). Among the subset of 63 patients
with no histopathologic abnormalities of the uterus or
adnexa, 38.1% (24/63) reported persistent pain after 1
year, including 9.5% (6/63) with pain that had increased
or was unchanged.9 In a study by Stovall et al3 involving
99 patients who underwent hysterectomy for CPP, 22%
(22/99) reported persistent pain following the procedure.
These results suggest that the source of CPP may be
nongynecologic in many cases and may not require sur-
gical intervention.
In clinical practice, endometriosis, abdominal/pelvic ad-
hesions, irritable bowel syndrome, and interstitial cystitis
(IC) are most frequently associated with CPP.2 Symptoms
of IC, in particular, may mimic gynecologic disorders, and
include voiding symptoms, dyspareunia, flare-ups after
sex, and perimenstrual exacerbations of pain.10
A study by Clemons et al11 showed that among women
with CPP, 38% (17/45) were diagnosed with IC. In addi-
tion, a recent retrospective study12 of 60 patients with CPP
found that at least 80% (48/60) of patients had both en-
dometriosis and IC, suggesting that these disorders fre-
quently overlap in patients with CPP. Differences in the
rates of IC diagnosis between studies may be due to
differences in patient populations or in the criteria used
for diagnosis.
Diagnosis of IC can be difficult; however, several methods
are available to facilitate an accurate diagnosis. A simple
questionnaire called the Pelvic Pain and Urgency/Fre-
quency (PUF) patient symptom scale can be used as an
effective screening tool to identify patients suspected of
having IC.13 The PUF questionnaire is an 8-question symp-
tom scale that measures the presence and severity of
symptoms on a scale of 1 to 35, and the extent to which
each patient is bothered by those symptoms. A score of
15 is highly suggestive of IC. The PUF questionnaire
may also be used to assess patient outcomes after therapy.
This questionnaire has been validated by the Potassium
Sensitivity Test (PST), which is used to confirm the pres-
ence of IC.13 The PST involves instilling a solution con-
taining potassium chloride (KCl) into the bladder and
assessing symptoms. A study by Parsons et al14 found
increased bladder sensitivity to potassium, a marker for
IC, in 85% (114/134) of patients with pelvic pain. In
addition, cystoscopy has been shown to be effective in
confirming the presence of IC with pathologic evidence
such as glomerulations or Hunner’s ulcers, or both.11
Once IC is diagnosed, effective treatments are available,
including oral therapy with pentosan polysulfate sodium
(PPS).15–18 Changes in diet and avoidance of certain foods
may also help to lessen symptom severity in some pa-
tients.19 In advanced cases, multimodal therapy with hy-
droxyzine, amitriptyline, gabapentin, or narcotics may be
used for further symptom relief.20–22 Cystoscopic hydro-
distention (CH) and instillation therapy with dimethyl sul-
foxide and other agents are additional useful treatment
modalities for acute flare-ups of IC.19,20
METHODS
A study to investigate the prevalence of bladder-origin
pain/IC in patients with posthysterectomy CPP, and to
evaluate the efficacy of various treatment regimens includ-
ing dietary modification, PPS, or CH, or both PPS and CH
together, was conducted from October 2000 to November
2002 at the Midwest Regional Center for Chronic Pelvic
Pain in Lima, Ohio. This study included 111 patients (age
range, 34 to 65 years) with persistent or recurrent pelvic
pain who had undergone hysterectomy with or without
oophorectomy for the treatment of CPP from 1979 to 2001.
All patients were evaluated using the PUF questionnaire, a
PST, and a physical examination to identify lower abdom-
inal, anterior vaginal wall tenderness, or bladder tender-
ness, or both. The PST involved first instilling 40 mL of
water and then 40 mL of 0.4 M KCl for 5 minutes each.
Subjective responses of urinary urgency or pain were
recorded on a scale of 0 to 5. A provocation of symptoms
resulting in an increase of 2 or more on either scale was
considered positive.23 Confirmation of IC by cystoscopy
Table 1.
Symptom Improvement Data From the Maryland Women’s
Health Study (N  1299)*8
Symptom Before Hysterectomy Postoperative
Follow-Up
1 Year 2 Years
Vaginal bleeding 59.2 0.5 0.3
Pelvic pain 63.1 8.5 7.8
Back pain 43.1 46.4 17.4
Activity limitation 57.5 4.1 2.4
Sleep disturbance 40.9 21.8 20.6
Fatigue 70.0 26.7 24.7
Abdominal bloating 47.8 13.5 12.1
Urinary incontinence 19.5 8.5 8.3
*Values are percentages unless otherwise indicated.
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Institute of Diabetes and Digestive and Kidney Diseases
(NIH-NIDDK) guidelines.24
Regardless of PUF or PST results, all patients were coun-
seled regarding changes in diet, such as elimination of hot
or spicy foods and foods high in potassium. Patients were
also asked to follow a low-acid /low-oxalate diet. Those
patients with a positive PST were offered treatment with
either dietary modification alone or dietary modification
in combination with CH (the bladder was distended for at
least 2 minutes with sterile water under 80 cm to 100 cm
of hydrostatic pressure), or oral therapy with PPS (200 mg
bid), or both (Figure 1). Patients who had a negative PST
but experienced severe pain were treated with dietary
modification in addition to CH (Figure 1). Patients were
followed up for at least 6 months (range, 6 to 25) and
improvements were noted by changes from baseline PUF
scores.
RESULTS
Irritative voiding symptoms were present in 94% (104/
111) of patients. The mean PUF score at presentation was
14.47, and 57% (63/111) of patients had a PUF score of 14
or higher. Eighty-eight (79%) patients had a positive PST
response, indicating bladder dysfunction consistent with
IC. Of the 66 patients who went on to receive CH, 92%
(61/66) had cystoscopic evidence of IC. Only 3 of the
patients with a positive PST who went on to receive CH
had no cystoscopic evidence of IC. Of the 10 patients who
had a negative PST and opted for CH, 9 had cystoscopic
evidence of IC.
Of the 23 (21%) patients with a negative PST, 10 (9%) were
treated with dietary modification alone, 10 (9%) were
treated with dietary modification plus CH, and 3 (3%)
were treated with dietary modification plus PPS. Of the 88
(79%) patients with a positive PST, 23 (21%) were treated
with dietary modification alone and 88 (79%) were treated
with dietary modification in combination with PPS or CH,
or both (Figure 1). Fifty-two patients received both PPS
and CH. Nine patients received PPS alone and 4 patients
received CH alone.
The follow-up period was at least 6 months. Table 2
shows mean PUF scores before and after treatment irre-
spective of PST result. For patients treated with dietary
modification alone, the mean PUF score decreased from
13.18 at baseline to 11.15 at follow-up, an improvement of
15.4% (Table 2). Mean PUF scores for patients treated
with PPS or CH, or both, plus dietary modification were
15.01 at baseline and 9.87 after therapy, an improvement
of 34.2%, which is nearly double the improvement com-
pared with the improvement in the group treated with
dietary modification alone.
DISCUSSION
Chronic pelvic pain is a common condition with numer-
ous potential causes that are often difficult to diagnose
and treat. Patients with CPP of bladder origin are often
misdiagnosed and undergo multiple diagnostic and surgi-
cal procedures resulting in little or no symptom relief.19
Until recently, IC has largely been ignored and consider-
ably underdiagnosed as a cause of CPP. If the diagnosis of
Figure 1. Potassium Sensitivity Test results and treatment deci-
sions. CHcystoscopic hydrodistention; PPSpentosan polysul-
fate sodium; PSTPotassium Sensitivity Test.
Table 2.
Mean PUF Scores Before and After Treatment Regardless of
PST Result*
PUF Score All Patients
(n  111)
PPS and/or
CH  Diet
(n  78)
Diet Alone
(n  33)
Baseline 14.47 15.01 13.18
Follow-up (6 mo) 10.25 9.87 11.15
Improvement, %† 29.2 34.2 15.4
*CH  cystoscopic hydrodistention; PPS  pentosan polysulfate
sodium; PST  Potassium Sensitivity Test; PUF  Pelvic Pain and
Urgency/Frequency.
†A decrease in score on the PUF questionnaire indicates symp-
tom improvement.
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be performed unnecessarily in women with CPP. Accurate
diagnosis and nonsurgical treatment of IC may relieve the
symptoms of CPP.
In this study, approximately 80% of women with persis-
tent posthysterectomy CPP were diagnosed with bladder
dysfunction based on the PST. Of the patients who re-
ceived CH as part of their therapy, 80% had both a positive
PST response and cystoscopic evidence of IC. Patients
who were treated with CH or oral PPS, or both, showed
improvement in bladder-related symptoms after 3 to 6
months, as evaluated with the PUF questionnaire. Even
women who were treated with a low-potassium diet alone
showed some improvement in bladder symptoms, al-
though improvement was not as great as that with CH or
PPS. These results suggest that bladder dysfunction may
have been the source of pain for many of these women
with posthysterectomy CPP. Other studies have also
found that the prevalence of IC in patients with CPP is
notable, suggesting that IC should be considered a pri-
mary diagnosis in these patients.2,11,12,14
Based on a review of the literature and results of the
recently completed study, it is recommended that gyne-
cologists rule out nongynecologic causes of pain before
performing a hysterectomy in patients with CPP. Proper
evaluation for bladder dysfunction, including a thorough
medical history and physical examination to assess blad-
der tenderness, is critical to making an accurate diagnosis.
In the study presented here, 92% (81/88) of patients with
positive PST also had positive CH. This suggests that
positive PST may be sufficient for a diagnosis of IC. Cys-
toscopy with hydrodistention may be used for diagnosis
of IC in patients with a negative PST and significant pelvic
pain and bladder tenderness. If the bladder is determined
to be the source of pelvic pain, proper treatment of IC
with PPS in combination with other therapies may result
in effective relief of pelvic pain and urinary symptoms,
thereby avoiding unnecessary surgery.
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